Ghana’s Yemaachi Biotechnology which focuses on immuno-genomics, bioinformatics, and artificial intelligence selected for Y Combinator’s 2021 Summer Cohorts.
American seed funding accelerator, Y Combinator which invests $125k in selected startups in exchange for 7% equity every two years, has selected Ghana’s Yemaachi Biotechnology for their 2021 Summer Batch of startups.
This year’s batch has seen about a 90% increase from the startups that were involved last year, with 15 being from Africa. The startups are supposed to present their products at the Demo Days on August 31 and September 1. 189 pitched on the first day, with the rest pitching on September 1, 2021.
Ghana’s Yemaachi Biotechnology, founded by Yaw Bediako, Yaw Attuah-Afari, David Hutchful, and Joyce Ngoi in 2020, was set up to diversify precision cancer diagnostics and treatments across Africa. The company is working to lower the burden that cancer causes by creating molecular diagnostics specifically optimised for Africans.
Yemaachi uses immunogenomics, bioinformatics and artificial intelligence to accelerate the development of cancer detection and cure strategies, ultimately with the goal of lowering the economic burden of cancer on the African continent.
It is one of the few companies in this year’s cohort that isn’t focused on financial technology but rather on biotechnology.
About Y Combinator
Y Combinator was set up to provide funding for early-stage startups. The organization works with these startups for three months, to get them into the best possible shape of their pitch to investors. Each cycle culminates in Demo Day, when the startups present their companies to a carefully selected audience. After that, the alumni network continues to work together to grow the companies.
Watch the Yemaachi Biotech: Africa’s Cancer Research Company video below
